BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 165002)

  • 1. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.
    Guyda H; Friesen H; Bailey JD; Leboeuf G; Beck JC
    Can Med Assoc J; 1975 Jun; 112(11):1301-9. PubMed ID: 165002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth increments with low dose intermittent growth hormone and fluoxymesterone in first year of therapy in hypopituitarism.
    Kirkland RT; Clayton GW
    Pediatrics; 1979 Mar; 63(3):386-8. PubMed ID: 220585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
    Zadik Z; Chalew S; Zung A; Landau H; Leiberman E; Koren R; Voet H; Hochberg Z; Kowarski AA
    J Pediatr; 1994 Aug; 125(2):189-95. PubMed ID: 8040760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
    Kedzia A; Obara-Moszyńska M; Korman E; Rabska-Pietrzak B; Kopinski P; Trojan J; Goździcka-Józefiak A
    Rocz Akad Med Bialymst; 2003; 48():28-33. PubMed ID: 14737937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
    Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
    Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthetic human growth hormone: current status and future questions.
    Thompson RG; Conforti P; Holcombe J
    J Endocrinol Invest; 1989; 12(8 Suppl 3):35-9. PubMed ID: 2809097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypopituitarism with recombinant somatropin for 1 year.
    Takano K; Shizume K; Hibi I; Okuno A; Hanyu K; Suwa S; Nakajima H; Kondo T; Kato K; Iwatani N
    Acta Paediatr Scand Suppl; 1988; 347():169-75. PubMed ID: 3254031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response to treatment with pituitary growth hormone: the New Zealand experience.
    Livesey JH; Cuneo RC; Donald RA; Harris RG; Ibberston HK; Costello JM; Holdaway IM; Gluckman PD; Fraser TR; Chapman GE
    N Z Med J; 1989 Aug; 102(873):399-402. PubMed ID: 2761875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of children with short stature.
    O'Shea D; Byrne M; Powell D
    Ir Med J; 1990 Mar; 83(1):25-7. PubMed ID: 2361835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose single weekly injections of growth hormone: response during first year of therapy of hypopituitarism.
    Rosenbloom AL; Riley WJ; Silverstein JH; Garnica AD; Netzloff ML; Weber FT
    Pediatrics; 1980 Aug; 66(2):272-6. PubMed ID: 7402812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
    Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment with human growth hormone in children with pituitary insufficiency under 7 years of age. Study of 26 cases].
    Mugnier E; Ployard F; Roy MP; Fermanian J; Rappaport R
    Arch Fr Pediatr; 1985 Oct; 42(8):671-6. PubMed ID: 4074096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Authentic recombinant human growth hormone. Results of a multicenter clinical trial in patients with growth hormone deficiency.
    Rasmussen LH; Zachmann M; Nilsson P
    Helv Paediatr Acta; 1989 Jun; 43(5-6):443-8. PubMed ID: 2663792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone.
    Lippe BM; Van Herle AJ; LaFranchi SH; Uller RP; Lavin N; Kaplan SA
    J Clin Endocrinol Metab; 1975 Apr; 40(4):612-8. PubMed ID: 165211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone treatment for short stature.
    Van Vliet G; Styne DM; Kaplan SL; Grumbach MM
    N Engl J Med; 1983 Oct; 309(17):1016-22. PubMed ID: 6684729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Delay of constitutional development--studies on therapy with growth hormone].
    Butenandt O
    Klin Padiatr; 1984; 196(2):69-72. PubMed ID: 6737950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of constitutional delay of growth and adolescence with human growth hormone.
    Bierich JR
    Klin Padiatr; 1983; 195(5):309-16. PubMed ID: 6632708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship in the treatment of hypopituitary children with human growth hormone: a retrospective survey.
    Job JC; Chaussain JL; Garnier P; Rolland A; Joab N
    Acta Paediatr Scand Suppl; 1987; 337():93-105. PubMed ID: 3481186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to growth hormone treatment and final height after cranial or craniospinal irradiation.
    Sulmont V; Brauner R; Fontoura M; Rappaport R
    Acta Paediatr Scand; 1990 May; 79(5):542-9. PubMed ID: 2386044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.